BP000176-C003: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is less then 0.1 ng/ml, corresponding to a Specific Activity of 1.0 x 107 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000176-C040: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: p.pichia-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is less then 0.2 ng/ml, corresponding to a Specific Activity of 5.0 x 106 IU/ mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000176-CYT-221: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is < 0.1 ng/ml, corresponding to a Specific Activity of 11,100,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000176-CYT-324: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein, Pichia
Source:Pichia Pastoris-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is < 0.183 ng/ml, corresponding to a Specific Activity of 5.5 MIU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000176-CYT-222: Recombinant Mouse Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
N-terminal sequence analysis: Met-Ala-Pro-Thr-Arg.
The ED50 as determined by the dose-dependant stimulation of the proliferation of murine FDC-P1 cell line is < 0.2 ng/ml, corresponding to a Specific Activity of 5,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000176-CYT-395: Recombinant Rat Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
The ED50 is 0.001-0.01 ng/ml corresponding to a specific activity of 100-1,000 MIU/mg, determined by the dose dependent proliferation of murine MC/9 cells.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000176-CYT-089: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein, HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) and is typically 0.4-2 ng/ml.
Purity: > 95% by SDS-PAGE.BP000176-CYT-416: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein, Sf9
Source: Insect Cells-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is 0.1 ng/ml, corresponding to a Specific Activity of 10,000,000 IU/mg.
Purity: > 98% by SDS-PAGE.BP000176-CYT-477: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000176-CYT-724: Recombinant Canine Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: E. coli-derived.
The ED50 as calculated by the dose-dependent stimulation of the proliferation of human TF1 erythroleukemic cells is typically 1-4 ng/ml.
Purity: > 96.0% by RP-HPLC and SDS-PAGE.